arrow
S

Saeed Shoaie

king's college london
H指数:33
被引数:5,526
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis

YAQ001对肝硬化患者肠道微生物组、通透性及全身炎症标志物的影响

2026-10-280
OAAI
Microbial resistance from genotype to metabolic phenotype

从基因型到代谢表型的微生物抗性

2026-10-210
OA
Whole blood transcriptomics atlas across human diseases

人类疾病全血转录组学图谱

2026-10-120
OAAI
SARS-CoV-2 Exposure Elicits a Strong Mucosal Antibody Response That May Facilitate Quicker Mucosal Viral Clearance

SARS-CoV-2暴露引发强烈的黏膜抗体反应,这可能促进更快的黏膜病毒清除

2026-09-180
OA
Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis – Authors' reply

治疗漂移还是制剂漂移:避免对利福昔明和肝硬化中抗菌耐药性的误解——作者回复

2026-08-050
PRE
Regulatory and metabolic control of microbial biosynthetic gene clusters

微生物生物合成基因簇的调控与代谢控制

2026-07-170
OAAI
Multiomics analyses in young grade C molar incisor pattern periodontitis

年轻C级磨牙切牙模式牙周炎的多组学分析

2026-07-010
PRE
Urea supplementation is associated with holistic changes in suprathreshold non-volatile flavour perception through oral microbiome carbon metabolism

尿素补充与通过口腔微生物群碳代谢对超阈值非挥发性风味感知的整体变化相关

2026-06-270
OAAI
Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosis

整合宿主-微生物组建模揭示了口腔-肠道易位在晚期肝硬化中的意义

iMeta
IF33.2
2026-05-010
OAAI
Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship

利福昔明在肝硬化中的应用:当治疗漂移遭遇抗菌药物管理

2026-04-160
PRE
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals

Menozzi, E.; Ren, Y.; Geiger, M.; Macnaughtan, J.; Avenali, M.; Toffoli, M.; Schapira, A.H.V. 帕金森病的微生物组特征:在健康个体和遗传易感个体中的表现。Nat. Med. 2026. online ahead of print. [Google Scholar] [CrossRef]

2026-04-011
OA
Temporal dynamics of gut biosynthetic gene clusters link persistent colonization and engraftment in fecal microbiota transplantation

肠道生物合成基因簇的时间动态将持续性定植与粪菌移植中的定植联系起来

2026-02-250
OA
Fungal infection drives metabolic reprogramming in epithelial cells via aerobic glycolysis and an alternative TCA cycle shunt
2026-02-040
OA
Distinct epidermal cell populations and single-cell gene expression signatures are associated with Staphylococcus aureus in atopic dermatitis

特异的表皮细胞群体和单细胞基因表达特征与特应性皮炎中的金黄色葡萄球菌相关

2026-01-010
PRE
Microbial collagenase activity is linked to oral–gut translocation in advanced chronic liver disease

微生物胶原蛋白酶活性与晚期慢性肝病中的口腔-肠道易位相关。

2025-12-290
OAAI
L-proline supplementation affects non-volatile flavour perception through oral microbiome metabolic pathways

L-脯氨酸补充剂通过口腔微生物群代谢通路影响非挥发性风味感知

2025-11-250
OAAI
Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson's disease and cognitive decline pathophysiology

口腔-肠道-大脑轴中致病性的微生物组特征影响帕金森病和认知衰退的病理生理学

2025-05-270
OAAI
Extensively acquired antimicrobial-resistant bacteria restructure the individual microbial community in post-antibiotic conditions

广泛获得的抗菌耐药细菌在抗生素治疗后条件下重塑个体微生物群落

2025-05-140
OA
Nitrate supplementation affects taste by changing the oral metabolome and microbiome

硝酸盐补充通过改变口腔代谢组和微生物组影响味道。

2025-05-020
OA
Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial
2025-01-060
OAAI